Your browser doesn't support javascript.
loading
Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer.
Davis, Jillian; Martin, Stewart G; Patel, Poulam M; Green, Andrew R; Rakha, Emad A; Ellis, Ian O; Storr, Sarah J.
Affiliation
  • Storr SJ; Academic Clinical Oncology, University of Nottingham, Division of Cancer and Stem Cells, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham NG5 1 PB, UK. sarah.storr@nottingham.ac.uk.
BMC Cancer ; 14: 995, 2014 Dec 23.
Article in En | MEDLINE | ID: mdl-25539577
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Calpain Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Calpain Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: Reino Unido